TRIPS, the Doha Declaration and increasing access to medicines: policy options for Ghana

There are acute disparities in pharmaceutical access between developing and industrialized countries. Developing countries make up approximately 80% of the world's population but only represent approximately 20% of global pharmaceutical consumption. Among the many barriers to drug access are th...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, JC, Gyansa-Lutterodt, M, Torpey, K, Esmail, LC, Kurokawa, G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1334179/
https://www.ncbi.nlm.nih.gov/pubmed/16336685
http://dx.doi.org/10.1186/1744-8603-1-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1334179/
https://www.ncbi.nlm.nih.gov/pubmed/16336685
http://dx.doi.org/10.1186/1744-8603-1-17

Ejemplares similares